Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 5 (2008), Issue 8 (August)

1. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
   Psychol Med, 38(9): 1257-66. [Abstract] [Full-text]
2. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
   Psychol Med, 38(9): 1309-17. [Abstract] [Full-text]
3. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
   Psychol Med, 38(9): 1241-9. [Abstract] [Full-text]
4. Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity.
   Ann Neurol, 64(1): 42-52. [Abstract] [Full-text]
5. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
   Psychol Med, 38(9): 1319-30. [Abstract] [Full-text]
6. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample.
   Psychol Med, 38(9): 1267-76. [Abstract] [Full-text]
7. Cannabis use and genetic predisposition for schizophrenia: a case-control study.
   Psychol Med, 38(9): 1251-6. [Abstract] [Full-text]
8. Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.
   Phytother Res, 22(8): 1017-24. [Abstract] [Full-text]
9. Polydrug use, cannabis, and psychosis-like symptoms.
   Hum Psychopharmacol, 23(6): 475-85. [Abstract] [Full-text]
10. A brief cannabis-associated problems questionnaire with less potential for bias.
    Hum Psychopharmacol, 23(6): 487-93. [Abstract] [Full-text]
11. Sensitivity and specificity of urinary cannabinoid detection with two immunoassays after controlled oral administration of cannabinoids to humans.
    Ther Drug Monit, 30(4): 530-5. [Abstract] [Full-text]
12. Socioeconomic and drug use determinants of smoking status in an urban adult population of Black African descent.
    Nicotine Tob Res, 10(8): 1319-25. [Abstract] [Full-text]
13. Implicit cognition and substance use: a meta-analysis.
    Addict Behav, 33(10): 1314-28. [Abstract] [Full-text]
14. Measured environmental contributions to cannabis abuse/dependence in an offspring of twins design.
    Addict Behav, 33(10): 1255-66. [Abstract] [Full-text]
15. Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves.
    Eur J Pharmacol, 591(1): 284-92. [Abstract] [Full-text]
16. Are we becoming more alike? Comparison of substance use in Australia and the United States as seen in the 1995, 1998, 2001 and 2004 national household surveys.
    Drug Alcohol Rev, 27(5): 473-81. [Abstract] [Full-text]
17. Two ways of estimating the euro value of the illicit market for cannabis in France.
    Drug Alcohol Rev, 27(5): 466-72. [Abstract] [Full-text]
18. Links between ethnic identification, cannabis use and dependence, and life outcomes in a New Zealand birth cohort.
    Aust N Z J Psychiatry, 42(9): 780-8. [Abstract] [Full-text]
19. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
    Neuropsychopharmacology, 33(10): 2505-16. [Abstract] [Full-text]
20. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad.
    Acta Psychiatr Scand, 118(3): 209-13. [Abstract] [Full-text]
21. Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder.
    J Psychiatr Res, 42(12): 1017-23. [Abstract] [Full-text]
22. Headspace sampling and detection of cocaine, MDMA, and marijuana via volatile markers in the presence of potential interferences by solid phase microextraction-ion mobility spectrometry (SPME-IMS).
    Anal Bioanal Chem, 392(1): 105-13. [Abstract] [Full-text]
23. One-year follow-up evaluation of Project Towards No Drug Abuse (TND-4).
    Prev Med. [Abstract] [Full-text]
24. Estimating community drug abuse by wastewater analysis.
    Environ Health Perspect, 116(8): 1027-32. [Abstract] [Full-text]
25. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.
    Neurogastroenterol Motil, 20(8): 919-27. [Abstract] [Full-text]
26. Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats.
    Brain Res, 1228: 145-60. [Abstract] [Full-text]
27. Violence involvement, substance use, and sexual activity among Mexican-American and European-American adolescents.
    J Adolesc Health, 43(3): 285-95. [Abstract] [Full-text]
28. Affect dysregulation in cannabis abusers : A study in adolescents and young adults.
    Eur Child Adolesc Psychiatry, 17(5): 274-82. [Abstract] [Full-text]
29. Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis.
    Drug Metab Dispos, 36(9): 1917-21. [Abstract] [Full-text]
30. Two decades of treatment seeking for substance use disorders in Saudi Arabia: trends and patterns in a rehabilitation facility in Dammam.
    Drug Alcohol Depend, 97(3): 231-6. [Abstract] [Full-text]
31. Disrupted White Matter Integrity in Heroin Dependence: A Controlled Study Utilizing Diffusion Tensor Imaging.
    Am J Drug Alcohol Abuse. [Abstract] [Full-text]
32. Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
    J Nat Prod, 71(8): 1427-30. [Abstract] [Full-text]
33. Trajectories of Childhood Aggression and Inattention/Hyperactivity: Differential Effects on Substance Abuse in Adolescence.
    J Am Acad Child Adolesc Psychiatry. [Abstract] [Full-text]
34. Homicides committed by youth assailants: a retrospective study.
    Am J Forensic Med Pathol, 29(3): 219-23. [Abstract] [Full-text]
35. Endocannabinoids in the retina: From marijuana to neuroprotection.
    Prog Retin Eye Res. [Abstract] [Full-text]
36. Drug use and weight loss in HIV-infected Hispanic men.
    AIDS Care, 20(7): 868-75. [Abstract] [Full-text]
37. Real-world memory and executive processes in cannabis users and non-users.
    J Psychopharmacol, 22(7): 727-36. [Abstract] [Full-text]
38. An epidemic of fatal 3-methylfentanyl poisoning in Estonia.
    Int J Legal Med, 122(5): 395-400. [Abstract] [Full-text]
39. JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.
    Oncogene, 27(37): 5033-44. [Abstract] [Full-text]
40. Effect of intrapulmonary tetrahydrocannabinol administration in humans.
    J Psychopharmacol, 22(7): 707-16. [Abstract] [Full-text]

© 2004-2010 Marijuana Research Today. All Rights Reserved.